Rectal Cancer
TAMIS Surgery
Transanal local excision through the anal canal — no abdominal incision
TAMIS surgery reaches selected rectal lesions through the anal canal without an abdominal incision — natural-orifice transanal surgery, not full NOTES. TEM is the dedicated platform in the same family. The aim is full-thickness local excision when the lesion fits — not for every rectal tumor.
Local excision is oncologic surgery with a narrow indication. Size, site, grade, MRI, and margins decide. TAMIS is not TaTME (transanal total mesorectal excision).
Natural-orifice access
Reach the rectum through a natural orifice — no abdominal incision
In TAMIS the working channel is the anal canal, not the abdominal wall. For a suitable rectal lesion, the surgeon can dissect and complete a full-thickness excision inside the rectum under high-definition vision.
The rectum is reached through the anal canal, not through the abdominal wall.
Three ways to think about access
1
Abdominal approach
Access through the abdominal wall
2
TAMIS
Natural orifice, anal canal, rectum
3
Single-port robotic TAMIS
Natural orifice + one transanal port + wristed robotic instruments
Who may be a candidate?
TAMIS can be used for selected benign rectal lesions that cannot be safely removed endoscopically, and for carefully chosen low-risk T1 rectal cancers. Sphincter distance, lesion height, size, and MRI findings change the plan.
- Selected benign lesions not suited to endoscopic excision
- Low-risk T1 cancer in carefully chosen patients
- Small lesion, favorable grade, full-thickness feasibility
- No locally advanced features on MRI
Local excision alone is not standard for T2 disease
Local excision alone is generally not standard curative treatment for T2 rectal cancer. Lymph-node risk usually means radical surgery (TME) is required. Organ-preservation pathways may be discussed only in special multidisciplinary settings — not as routine “selected T2 = TAMIS.”
Normal-looking nodes on MRI do not reliably exclude microscopic nodal metastasis.
TEM and TAMIS
Both work through the anal canal. An abdominal incision is not part of this access. TEM is a dedicated platform. TAMIS uses a transanal port and camera for the same local-excision principle. Both need an en-bloc full-thickness specimen and a margin read.
Pathology risk features
Whether local excision is enough depends on depth of submucosal invasion, differentiation, lymphovascular invasion, tumor budding, and margins. High-risk pT1 or positive/uncertain margins lead to discussion of completion radical surgery.
Single-port robotic TAMIS
One transanal access point
The da Vinci Single Port (SP) system is one of the newer robotic platforms with technical features that fit transanal work especially well. This setup is also called da Vinci SP TAMIS. Through one transanal access point, a surgeon-controlled 3D camera and multi-jointed instruments can support dissection, suturing, and tissue handling in a narrow rectal lumen. A single cannula is designed to reduce the external-arm collisions that several robotic arms can create in a tight space. That is a design feature, not proof of fewer complications, faster recovery, or better cancer outcomes. How the platform is set up is on the da Vinci single-port page.
- One transanal access point
- Surgeon-controlled 3D vision
- Wristed instruments through the same port
- Dissection and suturing in a narrow lumen
TME and TaTME are different operations
Total mesorectal excision removes the mesorectum intact and is the core oncologic method for radical surgery of mid and low rectal cancer. TaTME is that excision done from below in selected patients. TAMIS is a platform for local excision of a selected lesion. Local excision does not remove lymph nodes.
After local excision
Pathology may lead to surveillance, extra treatment, or completion TME. Follow-up uses endoscopy and MRI. Poor selection raises local recurrence risk, which is why the indication stays narrow.
Common questions
Does TAMIS need an abdominal incision?
No. Access is through the anal canal. Abdominal-wall ports are not part of the plan.
Is TAMIS the same as TaTME?
No. TAMIS is local excision of a selected lesion. TaTME is transanal total mesorectal excision.
Is TAMIS alone enough for T2 cancer?
Usually not. Radical surgery is the standard for most T2 cancers; local excision alone is not routine.
Is single-port robotic TAMIS better for everyone?
Comparative evidence does not support that claim. Single-port offers technical features suited to a narrow transanal field. It is not a promise of better outcomes.
What if pathology is unfavorable?
High-risk features or a positive margin lead to a talk about salvage TME and/or further treatment. Pathology follow-up is essential.
Evidence
Scientific sources
Show sources · 4TEM/TAMIS for low-risk T1 and selected benign lesions. Local excision alone is not routine standard for T2; it does not clear nodes. TAMIS is not TaTME.
Evidence
Scientific sources
- Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upESMO · 2017 (see the ESMO GI portal for updates) · DOI: 10.1093/annonc/mdx224Open source
- NCCN Clinical Practice Guidelines in Oncology: Rectal CancerNCCN · Current versionOpen source
- ASCRS clinical practice guidelines libraryAmerican Society of Colon & Rectal Surgeons (ASCRS) · Guideline libraryOpen source
- Management of Locally Advanced Rectal Cancer: ASCO GuidelineAmerican Society of Clinical Oncology (ASCO) · 2024 · DOI: 10.1200/JCO.24.01160Open source
Source list last checked: 31 October 2026. (Page content review date may appear separately above.)